1. Home
  2. GNPX vs MSN Comparison

GNPX vs MSN Comparison

Compare GNPX & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$0.86

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Logo Emerson Radio Corporation

MSN

Emerson Radio Corporation

HOLD

Current Price

$0.44

Market Cap

9.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
MSN
Founded
2009
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
9.4M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
GNPX
MSN
Price
$0.86
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
732.3K
25.4K
Earning Date
05-11-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$77,829,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.32
52 Week High
$12.97
$0.85

Technical Indicators

Market Signals
Indicator
GNPX
MSN
Relative Strength Index (RSI) 20.65 56.78
Support Level $0.15 $0.35
Resistance Level $2.12 $0.46
Average True Range (ATR) 0.11 0.03
MACD -0.01 -0.00
Stochastic Oscillator 1.25 70.71

Price Performance

Historical Comparison
GNPX
MSN

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

About MSN Emerson Radio Corporation

Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.

Share on Social Networks: